Home > Special Features

Special Features

Filter by Year:2024 2023 2022 2021 2020 2019 2018 2017 2016 2014 2013 2012 2011 2010 2009 2008 2007 2006

30-Dec-2011

Edition 439 - Quarterly Review - Investors Pour $630 Million into Sector as Biotech Prices Fall 24.4% for 2011

23-Dec-2011

Edition 438 - QRxPharma Cuts Creative Deal with Actavis for MoxDuo

16-Dec-2011

Edition 437 - Probiomics and Hunter Immunology to Merge via Public Offer

9-Dec-2011

Edition 436 - Positive Phase I Trial Results for Antisense Therapeutics’ Acromegaly Drug Candidate

2-Dec-2011

Edition 435 - Tissue Therapies Bypasses ‘The Pharmocracy’ – Appoints Contract Sales Teams in Europe

25-Nov-2011

Edition 434 - Capital Inflows Support Later Stage Biotechs

11-Nov-2011

Edition 433 - Clinuvel Pharmaceuticals – Prepares to File Scenesse for Approval

4-Nov-2011

Edition 432 - Financial Execution Risk for Biotechs – Can They Fund the Business Plan?

28-Oct-2011

Edition 431 - Clear Path to Market for Starpharma's BV Product

21-Oct-2011

Edition 430 - Pharmaxis – Bronchitol Success in Europe!

1
2
3
4
5
Next